abstract |
The present invention relates to novel macrocycles and methods of using said macrocycles to treat hepatitis C infection in patients in need of such therapy. The present invention also relates to pharmaceutical compositions comprising a compound of the present invention, or a pharmaceutically acceptable salt, ester or prodrug thereof, in combination with a pharmaceutically acceptable carrier or excipient. |